Susan G. Komen® Commends Bill Introduction; Urges Quick Passage Susan G. Komen®, the world’s leading breast cancer organization, commends Representative Chantelle Nickson-Clark (D-Florissant) for working with Komen to expand eligibility for the MO HealthNet Breast and Cervical Cancer Treatment (BCCT) program, providing increased access to vital breast and cervical cancer treatment services. The BCCT program […]

ALBANY – Susan G. Komen®, the world’s leading breast cancer organization commends the State Assembly’s proposed funding increase of $2.5 million for the Cancer Services Program (CSP) in the FY2025 Budget. “Without access to early detection programs, many people who are uninsured are forced to delay or forgo screenings, which could lead to later-stage breast […]

Susan G. Komen® Commends Bill Introduction; Urges Quick Passage ST. PAUL – Susan G. Komen®, the world’s leading breast cancer organization, applauds Representative Patty Acomb (D-Minnetonka) for introducing legislation that would eliminate financial barriers to clinically appropriate genetic testing, as well as the recommended screenings based on the results of that testing. In Minnesota, more […]

Top 5 Ways Komen’s Patient Care Center Navigates People Through Their Breast Health Care Journey DALLAS – For many, the path to high-quality breast health care is complex and challenging even in the best circumstances. People from underresourced communities, especially women of color, encounter even more barriers to care as they make their way through a […]

Walgreens’ commitment significantly enhances Susan G. Komen’s mission, with strategic funding for critical research and community support Susan G. Komen®, the world’s leading breast cancer organization and Walgreens announced today another milestone in the transformative five-year collaboration that has not only propelled groundbreaking research in breast cancer but has also significantly expanded access to essential […]

SCREENS for Cancer Act Continues Breast Health Services Used By Millions WASHINGTON, DC – Following unanimous passage of the SCREENS for Cancer Act by the U.S. House Committee on Energy and Commerce, Susan G. Komen®, the world’s leading breast cancer organization, is urging the full U.S. House and Senate to pass the legislation without delay. […]

Susan G. Komen® Commends Bill Introductions; Urges Quick Passage SACRAMENTO – Susan G. Komen®, the world’s leading breast cancer organization, commends Senate President pro Tempore Emeritus Toni G. Atkins (D-San Diego) for working with Komen to expand eligibility for the Every Woman Counts (EWC) Program, providing increased access to vital breast and cervical cancer services. […]

Susan G. Komen® Urges Quick Passage So Millions Can Get the Care They Need Susan G. Komen®, the world’s leading breast cancer organization, today commended members of the U.S. House Energy and Commerce Health Subcommittee for passing the Screening for Communities to Receive Early and Equitable Needed Services (SCREENS) for Cancer Act, an important step […]

Susan G. Komen® Commends Introduction of Bill Focused on Advancing Early Breast Cancer Detection Susan G. Komen®, the world’s leading breast cancer organization, commends Representative Linda Featherston (D-Overland Park) and Representative Laura Williams (R-Lenexa) for working with Komen to eliminate financial barriers to earlier breast cancer detection by ensuring that everyone has equitable access to […]

When patients and scientists come together to fuel scientific discovery, advancements are possible in breast cancer research that can ultimately improve patient treatment and outcomes. Susan G. Komen®, the world’s leading breast cancer organization, plays a pivotal role as a convenor of researchers and patient advocates who can work together, share ideas and utilize big […]

Susan G. Komen® Commends Bill Introductions; Urges Quick Passage NASHVILLE – Susan G. Komen®, the world’s leading breast cancer organization, applauds Representative Rebecca Alexander (R-Jonesborough) and Senator Bo Watson (R-Hixson) for introducing legislation that would prohibit the use of step therapy protocols for cancer patients. Studies have shown that delays of over 12 weeks for […]